Home-based pulmonary rehabilitation for COPD using minimal resources: An economic analysis

Angela T. Burge, Anne E. Holland, Christine F. McDonald, Michael J. Abramson, Catherine J. Hill, Annemarie L. Lee, Narelle S. Cox, Rosemary Moore, Caroline Nicolson, Paul O'Halloran, Aroub Lahham, Rebecca Gillies, Ajay Mahal

Research output: Contribution to journalArticleResearchpeer-review

1 Citation (Scopus)

Abstract

Background and objective: This study aimed to compare the cost-effectiveness and cost-utility of home and centre-based pulmonary rehabilitation for adults with stable chronic obstructive pulmonary disease (COPD). Methods: Prospective economic analyses were undertaken from a health system perspective alongside a randomized controlled equivalence trial in which participants referred to pulmonary rehabilitation undertook a standard 8-week outpatient centre-based or a new home-based programme. Participants underwent clinical assessment prior to programme commencement, immediately following completion and 12 months following programme completion. They provided data for utility (quality-adjusted life years (QALY) determined using SF6D (utility scores for health states) calculated from 36-Item Short Form Health Survey version 2) and effectiveness (change in distance walked on 6-min walk test (Δ6MWD) following pulmonary rehabilitation). Individual-level cost data for the 12 months following programme completion was sourced from healthcare administration and government databases. Results: Between-group mean difference point estimates for cost (−$4497 (95% CI: −$12 250 to $3257), utility (0.025 (−0.038 to 0.086) QALY) and effectiveness (14 m (−11 to 39) Δ6MWD) favoured the home-based group. Cost-utility analyses demonstrated 63% of estimates falling in the dominant southeast quadrant and the probability that the new home-based model was cost-effective at a $0 threshold for willingness to pay was 78%. Results were robust to a range of sensitivity analyses. Programme completion was associated with significantly lower healthcare costs in the following 12 months. Conclusion: Home-based pulmonary rehabilitation provides a cost-effective alternative model for people with COPD who cannot access traditional centre-based programmes.

Original languageEnglish
Pages (from-to)183-190
Number of pages8
JournalRespirology
Volume25
Issue number2
DOIs
Publication statusPublished - Feb 2020

Keywords

  • chronic obstructive pulmonary disease
  • cost-benefit analysis
  • exercise therapy
  • healthcare costs
  • quality-adjusted life years

Cite this

Burge, Angela T. ; Holland, Anne E. ; McDonald, Christine F. ; Abramson, Michael J. ; Hill, Catherine J. ; Lee, Annemarie L. ; Cox, Narelle S. ; Moore, Rosemary ; Nicolson, Caroline ; O'Halloran, Paul ; Lahham, Aroub ; Gillies, Rebecca ; Mahal, Ajay. / Home-based pulmonary rehabilitation for COPD using minimal resources : An economic analysis. In: Respirology. 2020 ; Vol. 25, No. 2. pp. 183-190.
@article{aacc415904614f21a7497eb01064f65c,
title = "Home-based pulmonary rehabilitation for COPD using minimal resources: An economic analysis",
abstract = "Background and objective: This study aimed to compare the cost-effectiveness and cost-utility of home and centre-based pulmonary rehabilitation for adults with stable chronic obstructive pulmonary disease (COPD). Methods: Prospective economic analyses were undertaken from a health system perspective alongside a randomized controlled equivalence trial in which participants referred to pulmonary rehabilitation undertook a standard 8-week outpatient centre-based or a new home-based programme. Participants underwent clinical assessment prior to programme commencement, immediately following completion and 12 months following programme completion. They provided data for utility (quality-adjusted life years (QALY) determined using SF6D (utility scores for health states) calculated from 36-Item Short Form Health Survey version 2) and effectiveness (change in distance walked on 6-min walk test (Δ6MWD) following pulmonary rehabilitation). Individual-level cost data for the 12 months following programme completion was sourced from healthcare administration and government databases. Results: Between-group mean difference point estimates for cost (−$4497 (95{\%} CI: −$12 250 to $3257), utility (0.025 (−0.038 to 0.086) QALY) and effectiveness (14 m (−11 to 39) Δ6MWD) favoured the home-based group. Cost-utility analyses demonstrated 63{\%} of estimates falling in the dominant southeast quadrant and the probability that the new home-based model was cost-effective at a $0 threshold for willingness to pay was 78{\%}. Results were robust to a range of sensitivity analyses. Programme completion was associated with significantly lower healthcare costs in the following 12 months. Conclusion: Home-based pulmonary rehabilitation provides a cost-effective alternative model for people with COPD who cannot access traditional centre-based programmes.",
keywords = "chronic obstructive pulmonary disease, cost-benefit analysis, exercise therapy, healthcare costs, quality-adjusted life years",
author = "Burge, {Angela T.} and Holland, {Anne E.} and McDonald, {Christine F.} and Abramson, {Michael J.} and Hill, {Catherine J.} and Lee, {Annemarie L.} and Cox, {Narelle S.} and Rosemary Moore and Caroline Nicolson and Paul O'Halloran and Aroub Lahham and Rebecca Gillies and Ajay Mahal",
year = "2020",
month = "2",
doi = "10.1111/resp.13667",
language = "English",
volume = "25",
pages = "183--190",
journal = "Respirology",
issn = "1323-7799",
publisher = "John Wiley & Sons",
number = "2",

}

Home-based pulmonary rehabilitation for COPD using minimal resources : An economic analysis. / Burge, Angela T.; Holland, Anne E.; McDonald, Christine F.; Abramson, Michael J.; Hill, Catherine J.; Lee, Annemarie L.; Cox, Narelle S.; Moore, Rosemary; Nicolson, Caroline; O'Halloran, Paul; Lahham, Aroub; Gillies, Rebecca; Mahal, Ajay.

In: Respirology, Vol. 25, No. 2, 02.2020, p. 183-190.

Research output: Contribution to journalArticleResearchpeer-review

TY - JOUR

T1 - Home-based pulmonary rehabilitation for COPD using minimal resources

T2 - An economic analysis

AU - Burge, Angela T.

AU - Holland, Anne E.

AU - McDonald, Christine F.

AU - Abramson, Michael J.

AU - Hill, Catherine J.

AU - Lee, Annemarie L.

AU - Cox, Narelle S.

AU - Moore, Rosemary

AU - Nicolson, Caroline

AU - O'Halloran, Paul

AU - Lahham, Aroub

AU - Gillies, Rebecca

AU - Mahal, Ajay

PY - 2020/2

Y1 - 2020/2

N2 - Background and objective: This study aimed to compare the cost-effectiveness and cost-utility of home and centre-based pulmonary rehabilitation for adults with stable chronic obstructive pulmonary disease (COPD). Methods: Prospective economic analyses were undertaken from a health system perspective alongside a randomized controlled equivalence trial in which participants referred to pulmonary rehabilitation undertook a standard 8-week outpatient centre-based or a new home-based programme. Participants underwent clinical assessment prior to programme commencement, immediately following completion and 12 months following programme completion. They provided data for utility (quality-adjusted life years (QALY) determined using SF6D (utility scores for health states) calculated from 36-Item Short Form Health Survey version 2) and effectiveness (change in distance walked on 6-min walk test (Δ6MWD) following pulmonary rehabilitation). Individual-level cost data for the 12 months following programme completion was sourced from healthcare administration and government databases. Results: Between-group mean difference point estimates for cost (−$4497 (95% CI: −$12 250 to $3257), utility (0.025 (−0.038 to 0.086) QALY) and effectiveness (14 m (−11 to 39) Δ6MWD) favoured the home-based group. Cost-utility analyses demonstrated 63% of estimates falling in the dominant southeast quadrant and the probability that the new home-based model was cost-effective at a $0 threshold for willingness to pay was 78%. Results were robust to a range of sensitivity analyses. Programme completion was associated with significantly lower healthcare costs in the following 12 months. Conclusion: Home-based pulmonary rehabilitation provides a cost-effective alternative model for people with COPD who cannot access traditional centre-based programmes.

AB - Background and objective: This study aimed to compare the cost-effectiveness and cost-utility of home and centre-based pulmonary rehabilitation for adults with stable chronic obstructive pulmonary disease (COPD). Methods: Prospective economic analyses were undertaken from a health system perspective alongside a randomized controlled equivalence trial in which participants referred to pulmonary rehabilitation undertook a standard 8-week outpatient centre-based or a new home-based programme. Participants underwent clinical assessment prior to programme commencement, immediately following completion and 12 months following programme completion. They provided data for utility (quality-adjusted life years (QALY) determined using SF6D (utility scores for health states) calculated from 36-Item Short Form Health Survey version 2) and effectiveness (change in distance walked on 6-min walk test (Δ6MWD) following pulmonary rehabilitation). Individual-level cost data for the 12 months following programme completion was sourced from healthcare administration and government databases. Results: Between-group mean difference point estimates for cost (−$4497 (95% CI: −$12 250 to $3257), utility (0.025 (−0.038 to 0.086) QALY) and effectiveness (14 m (−11 to 39) Δ6MWD) favoured the home-based group. Cost-utility analyses demonstrated 63% of estimates falling in the dominant southeast quadrant and the probability that the new home-based model was cost-effective at a $0 threshold for willingness to pay was 78%. Results were robust to a range of sensitivity analyses. Programme completion was associated with significantly lower healthcare costs in the following 12 months. Conclusion: Home-based pulmonary rehabilitation provides a cost-effective alternative model for people with COPD who cannot access traditional centre-based programmes.

KW - chronic obstructive pulmonary disease

KW - cost-benefit analysis

KW - exercise therapy

KW - healthcare costs

KW - quality-adjusted life years

UR - http://www.scopus.com/inward/record.url?scp=85070762572&partnerID=8YFLogxK

U2 - 10.1111/resp.13667

DO - 10.1111/resp.13667

M3 - Article

C2 - 31418515

AN - SCOPUS:85070762572

VL - 25

SP - 183

EP - 190

JO - Respirology

JF - Respirology

SN - 1323-7799

IS - 2

ER -